PureTech Health (PRTC) Liabilities and Shareholders Equity (2019 - 2024)

PureTech Health (PRTC) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $602.6 million as the latest value for Q4 2024.

  • Quarterly Liabilities and Shareholders Equity fell 13.16% to $602.6 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2024, down 11.62% year-over-year, with the annual reading at $602.6 million for FY2024, 13.16% down from the prior year.
  • Liabilities and Shareholders Equity for Q4 2024 was $602.6 million at PureTech Health, down from $694.0 million in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $990.0 million in Q4 2020, with the low at $602.6 million in Q4 2024.
  • Average Liabilities and Shareholders Equity over 5 years is $787.1 million, with a median of $702.6 million recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity grew 5.19% in 2020, then fell 25.72% in 2022.
  • Over 5 years, Liabilities and Shareholders Equity stood at $990.0 million in 2020, then dropped by 4.44% to $946.0 million in 2021, then dropped by 25.72% to $702.6 million in 2022, then decreased by 1.23% to $694.0 million in 2023, then dropped by 13.16% to $602.6 million in 2024.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $602.6 million, $694.0 million, and $702.6 million for Q4 2024, Q4 2023, and Q4 2022 respectively.